Matches in Wikidata for { <http://www.wikidata.org/entity/Q33215194> ?p ?o ?g. }
- Q33215194 description "2005 nî lūn-bûn" @default.
- Q33215194 description "2005 թուականի Մայիսին հրատարակուած գիտական յօդուած" @default.
- Q33215194 description "2005 թվականի մայիսին հրատարակված գիտական հոդված" @default.
- Q33215194 description "2005年の論文" @default.
- Q33215194 description "2005年論文" @default.
- Q33215194 description "2005年論文" @default.
- Q33215194 description "2005年論文" @default.
- Q33215194 description "2005年論文" @default.
- Q33215194 description "2005年論文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005年论文" @default.
- Q33215194 description "2005년 논문" @default.
- Q33215194 description "article científic" @default.
- Q33215194 description "article scientific" @default.
- Q33215194 description "article scientifique (publié 2005)" @default.
- Q33215194 description "articol științific" @default.
- Q33215194 description "articolo scientifico" @default.
- Q33215194 description "artigo científico (publicado na 2005)" @default.
- Q33215194 description "artigo científico (publicado na 2005)" @default.
- Q33215194 description "artigo científico" @default.
- Q33215194 description "artikull shkencor" @default.
- Q33215194 description "artikulong pang-agham" @default.
- Q33215194 description "artykuł naukowy" @default.
- Q33215194 description "artículo científico publicado en 2005" @default.
- Q33215194 description "artículu científicu espublizáu en 2005" @default.
- Q33215194 description "bilimsel makale" @default.
- Q33215194 description "bài báo khoa học" @default.
- Q33215194 description "mokslinis straipsnis" @default.
- Q33215194 description "naučni članak" @default.
- Q33215194 description "scienca artikolo" @default.
- Q33215194 description "scientific article" @default.
- Q33215194 description "teaduslik artikkel" @default.
- Q33215194 description "tieteellinen artikkeli" @default.
- Q33215194 description "tudományos cikk" @default.
- Q33215194 description "vedecký článok" @default.
- Q33215194 description "vetenskaplig artikel" @default.
- Q33215194 description "videnskabelig artikel (udgivet 2005)" @default.
- Q33215194 description "vitenskapelig artikkel" @default.
- Q33215194 description "vitskapeleg artikkel" @default.
- Q33215194 description "vědecký článek" @default.
- Q33215194 description "wetenschappelijk artikel" @default.
- Q33215194 description "wissenschaftlicher Artikel" @default.
- Q33215194 description "επιστημονικό άρθρο" @default.
- Q33215194 description "мақолаи илмӣ" @default.
- Q33215194 description "мақолаи илмӣ" @default.
- Q33215194 description "наукова стаття, опублікована в травні 2005" @default.
- Q33215194 description "научна статия" @default.
- Q33215194 description "научная статья" @default.
- Q33215194 description "научни чланак" @default.
- Q33215194 description "научни чланак" @default.
- Q33215194 description "מאמר מדעי" @default.
- Q33215194 description "سائنسی مضمون" @default.
- Q33215194 description "مقالة علمية" @default.
- Q33215194 description "مقالهٔ علمی" @default.
- Q33215194 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33215194 description "บทความทางวิทยาศาสตร์" @default.
- Q33215194 description "სამეცნიერო სტატია" @default.
- Q33215194 name "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 name "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 name "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 type Item @default.
- Q33215194 label "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 label "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 label "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 prefLabel "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 prefLabel "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 prefLabel "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 P1433 Q33215194-2F084C5B-F6D3-43B0-A616-BFE353E40224 @default.
- Q33215194 P1476 Q33215194-3922CECF-17D5-41E1-92E6-83CCEBDB0AA3 @default.
- Q33215194 P2093 Q33215194-0B657DE9-BB4F-43CB-BF5F-604350F37897 @default.
- Q33215194 P2093 Q33215194-3C41B9DC-601C-496E-BC43-97F147C4E817 @default.
- Q33215194 P2093 Q33215194-4D5CB12C-F8D8-42F4-9C9C-C2564F67A098 @default.
- Q33215194 P2093 Q33215194-730C83D1-57D9-4E5B-83C8-49DF2787219F @default.
- Q33215194 P2093 Q33215194-8BAF733B-EAC4-4862-9303-EF2E87B077B6 @default.
- Q33215194 P2093 Q33215194-AEA50400-F8A7-40E5-9E2B-2F2A146BB29D @default.
- Q33215194 P2093 Q33215194-C4098D78-FE8C-4926-9683-70B6F1583C0E @default.
- Q33215194 P2093 Q33215194-EE7B79A6-E419-409E-8900-EFA5C5DB2F6C @default.
- Q33215194 P304 Q33215194-2C8F65E6-F17F-4AC8-9A6A-9CE54C15DB9F @default.
- Q33215194 P31 Q33215194-E6FBCF96-471F-49D1-BF5A-CD7E81E1FB15 @default.
- Q33215194 P356 Q33215194-A7874949-7FB7-4426-907D-AF8B9A7B2BCA @default.
- Q33215194 P407 Q33215194-34CC6AB7-9877-4A78-805C-2C1C6F6BFFAA @default.
- Q33215194 P433 Q33215194-64D9575D-0E13-4E13-95DE-826BD06D2976 @default.
- Q33215194 P478 Q33215194-7A58E9AC-1FBC-4600-BE4A-8C98E8A9C93C @default.
- Q33215194 P50 Q33215194-8F120DA5-E6F7-4D11-95CA-0A821385AF40 @default.
- Q33215194 P577 Q33215194-D7A674DE-F27E-43EB-8F83-FBB9F2203BBD @default.
- Q33215194 P698 Q33215194-08ad9841-19db-4450-bfb3-aaefccfc1be2 @default.
- Q33215194 P698 Q33215194-2D59788B-619B-4323-B6AB-62B1971BD4D0 @default.
- Q33215194 P921 Q33215194-56412EAD-21D7-4250-8801-C779A77A7C34 @default.
- Q33215194 P356 1078-0432.CCR-04-1937 @default.
- Q33215194 P698 15897580 @default.
- Q33215194 P1433 Q332253 @default.
- Q33215194 P1476 "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors" @default.
- Q33215194 P2093 "Aletta Lems" @default.
- Q33215194 P2093 "André S T Planting" @default.
- Q33215194 P2093 "Ate van der Gaast" @default.
- Q33215194 P2093 "Inge Boot" @default.